Table 5.
Immune cell | Metabolic pathway | Metabolic reprogramming | Relevance of metabolic pathway to cellular function | Model | References |
---|---|---|---|---|---|
ILC1s and NK Cells | Glycolysis | ⇑ | Required for cytotoxicity and IFN-γ production Not required for NK cell degranulation |
IL-2 or IL-12/15-stimulated peripheral blood NK cells | (308) |
NK cell proliferation and cytotoxicity | IL-15-activated NK cells in vitro and MCMV infection in mice | (309) | |||
Oxidative Phosphorylation | ⇑ | IL-2 or IL-12/15-stimulated peripheral blood NK cells | (308) | ||
Primary murine NK cells | (310) | ||||
Not required for IFN-γ production | IL-12 and IL-18-stimulated primary murine NK cells | ||||
Required for NK cell activation | NK receptor-activating stimulation of primary murine NK cells | ||||
ILC2s | Glycolysis | ⇓ | Required for proliferation and cytokines production | Arg1-deficient ILCs in mice | (311, 312) |
? | Arg1-deficient ILC2s in a mouse model of helminth infection | (56) | |||
Required for ILC2 development | Conditional deletion of E3 ubiquitin ligase VHL in innate lymphoid progenitors | (313) | |||
Required for ILC2 homeostasis and cytokine production | Atg5−/− mice | (314) | |||
Fatty Acid Oxidation | ⇑ | Required for accumulation and production of IL-13 and IL-5 | Rag1−/− mouse model of helminth infection and malnutrition | (315) | |
Required for ILC2 homeostasis and cytokine production | Atg5−/− mice | (314) |
⇑, high metabolic rate; ⇓, low metabolic rate; ?, require further investigation.